Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cryogen-Free Technology for NMR

By HospiMedica staff writers
Posted on 18 May 2004
A new range of nuclear magnetic resonance (NMR) magnets are based on new technology that does not require refilling with cryogens, which will make NMR more widely available.

The ActivelyCooled 400-600 MHz NMR magnets include helium recondensing technology, which addresses NMR's standard dependency on maintaining levels of liquid cryogens. More...
This means that NMR will now be available to a wider use base of customers that either do not have cost-effective access to the essential cryogens or the on-site logistics needed to support the constant cryogen handling required for refilling conventional systems. The new magnets were jointly developed and tested by Oxford Instruments (Oxon, UK) and Varian, Inc. (Palo Alto, CA, USA) and were introduced at the Experimental Nuclear Magnetic Resonance Conference in Monterey (CA, USA) in April 2004.

NMR is a nondestructive, data-rich analytic method used in genomics and proteomics to identify the three-dimensional structure, function, and dynamics of nucleic acids, proteins, and other biologic macromolecules. The new NMR systems are cost-effective by removing system "downtime” associated with refilling cryogens and are significantly more compact because there is no need for a separate nitrogen vessel.

This new technology, developed by Oxford Instruments, includes a pulse tube refrigerator (PTR) optimized to the cooling power requirements of NMR. PTR technology provides a cold section that has no moving parts, which is crucial for NMR applications because it means that there is minimal vibration. Also, all moving parts are at room temperature and therefore easily maintained.

The design of the ActivelyCooled NMR magnets has also been optimized so that the PTR can be serviced efficiently, ensuring the minimum of down time with service intervals being potentially up to 24 months. In addition, the cryostat is capable of maintaining its magnetic field for up to 12 hours in the event of power failure, preventing excessive service costs in the power outages.



Related Links:
Oxford Instruments
Varian, Inc.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.